CN Patent

CN116261470A — 用于制备超声波造影剂的方法和装置

Assigned to Lantheus Medical Imaging Inc · Expires 2023-06-13 · 3y expired

What this patent protects

本文提供了用于识别和/或区分UCA配制品及具体地活化此类配制品以产生适合于体内使用的UCA的方法和装置。

USPTO Abstract

本文提供了用于识别和/或区分UCA配制品及具体地活化此类配制品以产生适合于体内使用的UCA的方法和装置。

Drugs covered by this patent

Patent Metadata

Patent number
CN116261470A
Jurisdiction
CN
Classification
—
Expires
2023-06-13
Drug substance claim
No
Drug product claim
No
Assignee
Lantheus Medical Imaging Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.